Effects of sodium saccharin and linoleic acid on mRNA levels of Her2/neu and p53 in a human breast epithelial cell line

Cancer Letters

Volumn 102, Issue 1-2, 1996, Pages 91-99

  Ogretmen, Besim ^a,d   Ratajczak, Helen ^a,b   Gendel, Steven M ^a,c   Stark, Benjamin C ^a  

^a Illinois Institute of Technology   (United States)

^b IIT RESEARCH INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Her2 neu; Linoleic acid; P53; Phorbol 12 myristate 13 acetate; Sodium saccharin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; LINOLEIC ACID; MESSENGER RNA; METHYLNITROSOUREA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53; SACCHARIN SODIUM; TUMOR PROMOTER;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0029871959     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04170-5     Document Type: Article

References (50)

1. Dubik, D., Dembinski, T.C. and Shiu, R.P.C. (1987) Stimulation of c-myc oncogene expression associated with estrogen induced proliferation of human breast cancer cells. Cancer Res., 47, 6517-6521.
2. Borek, C. (1980) Oncogenes, hormones and free radical processes in malignant transformation in vitro. Nature, 183, 776-778.
3. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, G., Udove, J., Ullrich, A. and Press, M.F. (1989) Studies of the Her2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707-712.
4. Travail, S., Koniecki, J., Petralia, S. and Baserga, R. (1990) Oncogenes in growth and development. FASEB J., 4, 3209-3214.
5. Schechter, A.L., Stern D.S., Vaidyanathan. L., Decker, S.J., Drebin, J.A., Greene, M.I., and Weinberg, R.A. (1984) The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature, 312, 513-516.
6. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
7. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F. and Minna, J.D. (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
8. Jenkins, J.R., Rudge, K., Chumakov, P. and Currie, J.A. (1985) The cellular oncogene p53 can be activated by mutagenesis. Nature, 317, 816-818.
9. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymor, S., Kinzler, K.W. and Vogelstein, B. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
10. Mulligan, L.M., Matashewski, G.J., Scrable, H.J. and Cavenee, W.K. (1990) Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 87, 5863-5867.
11. Hudziak, R.M., Schlessinger, J. and Ullrich, A. (1987) Increased expression of the putative growth factor receptor p185Her2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
12. Bacus, S.S., Ruby, S.G., Weinberg, D.S., Chin, D., Ortiz, R. and Bacus, J.W. (1990) Her2/neu oncogene expression and proliferation in breast cancers. Am. J. Pathol., 137, 103-111.
13. Masuda, H., Battifora, H., Yokota, J., Meltzer, S. and Cline, M.J. (1987) Specificity of protooncogene amplification in human malignant diseases. Mol. Biol. Med., 4, 213-227.
14. Imyanitov, E.N. and Knayazev, P.G. (1993) Prognostic significance of erbB-2 oncogene activation in human tumours. Exp. Oncol., 15, 3-9.
15. Van de Vijver, M.J. and Nusse, R. (1991). The molecular biology of breast cancer. Biochim. Biophys. Acta, 1072, 33-50.
16. Henderson, B.E., Ross, R.K. and Pike, M.C. (1991) Toward the primary prevention of cancer. Science, 254, 1131-1138.
17. Stenback, F., Peto, R. and Shubik, P. (1981) Initiation and promotion at different ages and doses in 2200 mice. Br. J. Cancer, 44, 15-23.
18. Honn, K.V., Bockman, R.S. and Marnett, L.J. (1981) Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins, 21, 833-863.
19. Nakanishi, K., Haglwara, A., Shibata, M., Imaida, K., Tatematsu, M. and Ito, N. (1980) Dose response of sodium saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with BBN. J. Natl. Cancer Inst., 65, 1005-1010.
20. Amdur, O.M., Doull, J. and Klaassen, C.D. (1991) Casarett and Doull's Toxicology. Pergamon Press, New York.
21. Birt, D.F., Kris, E.S., Choe, M. and Pelling, J.C. (1992) Dietary energy and fat effects on tumor promotion. Cancer Res., 52, 2035-2039.
22. Hill, M.J. (1987) Dietary fat and human cancer. AntiCancer, 7, 281-292.
23. Dwyer, J.T. (1988) Health aspects of vegetarian diets. Am. J. Clin. Nutr., 48, 712-738.
24. Rose, D.P., Connolly, J.M. and Meschter, C.L. (1991) Effects of dietary fat on human breast cancer growth and lung metastasis in nude mice. J. Natl. Cancer Inst., 83, 1491-1495.
25. Fischer, S.M., Leyton, J., Lee, M.L., Lockniskar, M., Belury, M.A., Maldve, R.E., Slaga T.G. and Bechtel, D.H. (1992) Differential effects of dietary linoleic acid on mouse skin tumour promotion and mammary carcinogenesis. Cancer Res., 52, 2049-2054.
26. Rose, D.P and Connolly, J.M. (1989) Stimulation of growth of human breast cancer cell lines in culture by linoleic acid. Biochem. Biophys. Res. Commun., 164, 277-283.
27. Elson, C.E. (1992) Tropical oils: nutritional and scientific issues. Crit. Rev. Food. Sci. Nutr., 31, 79-102, 1992.
28. Ames, B.N., Magaw , R. and Gold, L.S. (1987) Ranking possible carcinogenic hazards. Science, 236, 271-280.
29. Ames, B.N. and Gold, L.S. (1990) Too many rodent carcinogens: mitogenesis increases mitogenesis. Science, 249, 970-971.
30. Ashby, J. and Morrod, R.S. (1991) Detection of human carcinogens. Nature, 352, 185-186.
31. Ogiso, T., Tatematsu, M., Tamano, S., Hasegawa, R. and Ito, N. (1990) Correlation between medium term liver bioassay system data and results of long term testing in rats. Carcinogenesis, 11, 561-566.
32. American Type Culture Collection (1988) American Type Culture Collection Catalogue of Cell Lines and Hybridomas, 6th edn., Rockville, MD.
33. McCormick, D.L., Adamowski, C.B., Fiks, A. and Moon R. (1981) Lifetime dose-response relationships for mammary tumor induction by a single administration of NMU. Cancer Res., 41, 1690-1694, 1981.
34. Zarbl, H., Sukumar, S., Arthur, A.V., Zanca, D.M. and Barbacid, M. (1985) Direct mutagenesis of Ha-ras-1 oncogenes by NMU during initiation of mammary carcinogenesis in rats. Nature, 315, 382-385.
35. Stenback, F., Peto, R. and Shubik, P. (1981) Initiation and promotion at different ages and doses in 2200 mice. Methods and the apparent persistence of initiated cells. Br. J. Cancer, 44, 1-14.
36. Dwian, B.A., Ward, J.M., Henneman, J. and Wenk, M. (1985) Effects of short term exposure to the tumor promoter TPA on skin carcinogenesis in Sencar mice. Cancer Lett., 26, 177-184.
37. Hashimoto, Y., Tajima, O., Hashiba, H., Nose, K. and Kuroki, T. (1990) Elevated expression of secondary, but not early, responding genes to phorbol ester tumor promoters in papillomas and carcinomas of mouse skin. Mol. Carcinogenesis, 3, 302-308.
38. Ginsberg, D., Oren, M., Yaniv, M. and Piette, J. (1990) Protein binding elements in the promoter region of the mouse p53 gene. Oncogene, 5, 1285-1290.
39. Ilekis, J., Stark, B.C. and Benveniste, R. (1991) Expression of epidermal growth factor receptors at the mRNA and cell membrane levels in first trimester and term human placentae. Trophoblast Res., 5, 103-117.
40. Chattopadhyay, N., Kher, R. and Godbole, M. (1993) Inexpensive SDS/phenol method for RNA extraction from tissues. Biotechniques, 15, 24-25.
41. Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
42. Ogretmen, B., Ratajczak, H., Kats, A., Gendel, S.M., Stark, B.C. (1993) Effects of staining of RNA with ethidium bromide before electrophoresis on performance of Northern blots. Biotechniques, 14, 932-935.
43. Promega Product Catalogue (1993) Promega, Madison, WI.
44. Read, L.D., Keith, D., Slamon, D.J. and Katzenellenbogen, B.S. (1990) Hormonal modulation of Her2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res., 50, 3947-3951.
45. Hudziak, R.M., Lewis, G.D., Shalaby, M.R., Eessalu, T.E., Aggarwal, B.B., Ullrich, A. and Shephard, H.M. (1988) Amplified expression of the Her2/neu oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA, 85, 5102-5106.
46. Munson, G.P. and Woloschak, G.E. (1990) Differential effect of ionizing radiation on transcription in repair-deficient and repair-proficient mice. Cancer Res., 50, 5045-5048.
47. Anderson, A. and Woloschak, G.E. (1992) Cellular protooncogene expression following exposure of mice to gamma rays. Radiat. Res., 130, 340-344.
48. Haldar, S., Negrini, M., Monne, M., Sabbioni, S. and Croce, C.M. (1994) Down regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54, 2095-2097.
49. Ginsberg, D., Oren, M., Yaniv, M. and Piette, J. (1990) Protein binding elements in the promoter region of the mouse p53 gene. Oncogene, 5, 1285-1290.
50. Chappel, C.I. (1992) A review and biological risk assessment of sodium saccharin. Regul. Toxicol. Pharmacol., 15, 253-270.